Transcept Pharmaceuticals (TSPT)
Transcept Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -5.177M | 5.296M | -4.991M | -2.246M | -1.939M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.211M | 0.211M | 0.28M | 0.373M | 0.427M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 0.773M | 2.369M | 0.68M | 0.615M | 0.743M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 0.984M | 2.58M | 0.96M | 0.988M | 1.17M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | 0.646M | -0.445M | -1.279M | -2.278M | -3.523M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -3.547M | 7.431M | -5.31M | -3.536M | -4.292M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -0.002M | -0.017M | -0.002M | -0.029M | -0.011M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | -5.42M | -1.899M | 4.443M | 4.614M | -5.833M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | -5.422M | -1.916M | 4.441M | 4.585M | -5.844M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 0.629M | 1.088M | 0.027M | 0.242M | 0.023M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.629M | 1.088M | 0.027M | 0.242M | 0.023M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Change in Cash & Cash Equivalents | -8.34M | 6.603M | -0.842M | 1.291M | -10.11M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 10.66M | 13.72M | 10.66M | 4.056M | 4.898M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 2.319M | 10.66M | 4.056M | 4.898M | 3.607M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
